Abstract
DEFECTS in mitochondrial DNA (mtDNA) are associated with several different human diseases, including the mitochondrial encephalomyopathies. The mutations include deletions but also duplications and point mutations1. Individuals with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes) carry a common A-to-G substitution in a highly conserved portion of the gene for transfer RNALeu(UUR)(refs 2, 3). Although the MELAS mutation may be comparable to the defect in the tRNALys gene associated with MERRF (refs 4, 5) (myoclonus epilepsy associated with ragged-red fibres), it is also embedded in the middle of a tridecamer sequence necessary for the formation of the 3′ ends of 16S ribosomal RNA in vitro6. We found that the MELAS mutation results in severe impairment of 16S rRNA transcription termination, which correlates with a reduced affinity of the partially purified termination protein for the MELAS template. This suggests that the molecular defect in MELAS is the inability to produce the correct type and quantity of rRNA relative to other mitochondrial gene products.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lander, E. S. & Lodish, H. Cell 61, 925–926 (1990).
Goto, Y., Nonaka, I. & Horai, S. Nature 348, 651–653 (1990).
Kobayashi, Y. et al. Biochem. biophys. Res. Commun. 173, 816–822 (1990).
Shoffner, J. M. et al. Cell 61, 931–937 (1990).
Yoneda, M. et al. Biochem. Int. 21, 789–796 (1990).
Christianson, T. W. & Clayton, D. A. Molec. cell. Biol. 8, 4502–4509 (1988).
Christianson, T. W. & Clayton, D. A. Proc. natn. Acad. Sci. U.S.A. 83, 6277–6281 (1986).
Kruse, B., Narasimhan, N. & Attardi, G. Cell 58, 391–397 (1989).
Chomyn, A. and Attardi, G. Curr. Top. Bioenerget. 15, 295–329 (1987).
Tapper, D. P., Van Etten, R. A. & Clayton, D. A. Meth. Enzym. 97, 426–434 (1983).
Fisher, R. P. & Clayton, D. A. J. biol. Chem. 260, 11330–11338 (1985).
Hager, D. A. & Burgess, R. R. Analyt. Biochem. 109, 78–86 (1980).
Chodosh, L. A., Carthew, R. W. & Sharp, P. A. Molec. cell. Biol. 6, 4723–4733 (1986).
Fisher, R. P. & Clayton, D. A. Molec. cell. Biol. 8, 3496–3509 (1988).
Anderson, S. et al. Nature 290, 457–465 (1981).
Maxam, A. M. & Gilbert, W. Meth. Enzym. 65, 499–560 (1980).
Kunkel, T. A., Roberts, J. D. & Zakour, R. A. Meth. Enzym. 154, 367–382 (1987).
Galas, D. J. & Schmitz, A. Nucleic Acids Res. 5, 3157–3170 (1978).
Fisher, R. P., Topper, J. N. & Clayton, D. A. Cell 50, 247–258 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hess, J., Parisi, M., Bennett, J. et al. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies . Nature 351, 236–239 (1991). https://doi.org/10.1038/351236a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/351236a0
This article is cited by
-
Functional conservation of mitochondrial RNA levels despite divergent mtDNA organization
BMC Research Notes (2020)
-
Analysis of mitochondrial function in human induced pluripotent stem cells from patients with mitochondrial diabetes due to the A3243G mutation
Scientific Reports (2018)
-
Conformational Preferences of Modified Nucleoside 5-Taurinomethyluridine, τm5U Occur at ‘wobble’ 34th Position in the Anticodon Loop of tRNA
Cell Biochemistry and Biophysics (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
